NCT05743270 2025-03-11
Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
Replimune Inc.
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT01820312 2016-08-08
A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)
University of Arkansas
Phase 2 Withdrawn
NCT02013453 2014-12-02
A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer
University of Michigan Rogel Cancer Center
Phase 2 Withdrawn
NCT01701349 2014-05-01
FACT2
Mateon Therapeutics
Phase 3 Withdrawn